Graphite Bio
Why Robinhood?
You can watch Graphite Bio and buy or sell other stocks, ETFs, and their options commission-free!About GRPH
LENZ Therapeutics, Inc. is a pre-commercial biopharmaceutical company, which focuses on the development and commercialization of innovative therapies to improve vision. It offers eye drop product treatment for presbyopia.
GRPH Key Statistics
Stock Snapshot
As of today, Graphite Bio(GRPH) shares are valued at $13.90. The company's market cap stands at 397.38M, with a P/E ratio of -6.63.
On 2026-02-06, Graphite Bio(GRPH) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Graphite Bio(GRPH) stock has reached 0, versus its average volume of 1.12M.
Over the past 52 weeks, Graphite Bio(GRPH) stock has traded between a high of $50.40 and a low of $13.94.
Over the past 52 weeks, Graphite Bio(GRPH) stock has traded between a high of $50.40 and a low of $13.94.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.